SPOTLIGHT -
Poster Finds Inflammatory Commonality Between MDD and Dermatological Diseases
Poster at the 2024 APA Annual Meeting explores link between MDD, atopic dermatitis, psoriasis, and inflammation.
Using Artificial Intelligence in Clinical Practice
The president of the American Medical Association shares how AI can be useful to clinicians at the 2024 APA Annual Meeting.
The 2024 APA Annual Meeting: Saturday, May 4
Here are highlights from the first day of this year’s APA Annual Meeting.
Tardive Dyskinesia in US Antipsychotic Users
This 2024 APA Annual Meeting poster estimated the prevalence of tardive dyskinesia in antipsychotic users in the US, and found rates ranging from 94.1-127.4 per 1000 antipsychotic users.
Making Sense of Chatbots
How does artificial intelligence have the potential to shape the future of psychiatry?
Setting the Standard for Sports Psychiatry
How can we raise the standard of excellence in the field of sports psychiatry?
Addiction’s Seat at the Table: An Interview With Outgoing APA President
Petros Levounis, MD, MA, talks addiction, buprenorphine, his year as president of the APA, and more at the 2024 Annual Meeting.
Impacting Policies, Practices, and Other Physicians
Do you need to build leadership skills? Check out this 2024 APA Annual Meeting session from the American Association for Psychiatric Administration and Leadership!
Building Psychiatric Administrators and Leaders for the the Future
The President-Elect of the AAPAL sat down with Psychiatric Times at the 2024 APA Annual Meeting to discuss building leaders.
Semaglutide and Depression: What Is the Relationship?
This 2024 APA Annual Meeting poster investigated the relationship between antiobesity agents like semaglutide and depression.
An Artisanal Approach to Care: A Conversation with Joseph F. Goldberg, MD
Joseph F. Goldberg, MD, sat down with Psychiatric Times' Editor-in-Chief at the 2024 APA Annual Meeting.
Disability as the Next Step in DEI Explored at Annual Meeting
Speakers at the APA Annual Meeting share insights regarding to disability, both in patients and in clinicians.
Suicide and Other Deaths From Unnatural Causes in Bipolar Disorder
Are individuals with bipolar disorder more likely to die from unnatural causes than the general population?
An Update on Muscarinic Agonism as a Treatment for Schizophrenia
What makes this treatment option unique?
Reefer Madness in Youth
What are the connections between cannabis use and the onset of psychotic disorders?
ADHD, Stimulant Use, and Failure to Thrive in Pediatric Patients
This 2024 APA Annual Meeting poster covered a literature review on the relationship between stimulant use and failure to thrive in pediatric patients with ADHD.
A Protocol to Assist With Cannabis Use Disorder
Use this protocol, presented at the 2024 APA Annual Meeting, in patients with cannabis use disorder to bolster likelihood of cannabis cessation or reduction in use.
Look Beyond Stable: An Installation on Living With Schizophrenia
This interactive installation begs the question, “What is the truth of life with schizophrenia?”
Examining the Link Between Social Media Addiction and Psychiatric Emergencies in Youth
What is the potential impact of social media overuse and mental health crises in young patients?
A Dynamic Model for the Clinical Diagnosis of Adult ADHD
A look at 3 different psychiatric perspectives for successfully diagnosing ADHD in previously undiagnosed adults.
The Failed Concept of Treatment Resistance
Explore treatment resistance at the 2024 APA Annual Meeting!
Confronting Addiction From Prevention to Recovery
A look at the theme for the 2024 American Psychiatric Association Annual Meeting.
What is New in Geriatric Psychiatry?
An expert gives us a preview of the clinical pearls clinicians can expect from his presentations at this year’s APA Annual Meeting.
Abstinence vs Drinking in Moderation
Which is the best recommendation for the treatment of alcohol use disorder?
Destigmatizing Personality Disorders
Don't miss these 2 APA Annual Meeting sessions on personality disorders!
What Everyone Is Excited About at the 2024 APA Annual Meeting
We asked some of the presenters and attendees of the upcoming 2024 APA Annual Meeting what they were excited about. Here's what they said.
The Latest Updates on KarXT
The chief scientific officer and medical director of Segal Trials shares more on KarXT, a first in class for muscarinic agonists, and what he's excited about at the upcoming 2024 APA Annual Meeting.
Spotlight: The Psychiatric Times Editorial Board at APA 2024
Our Editorial Board members are delivering expert perspectives on a wide variety of psychiatric issues and disorders.
Addressing Gaps in the Treatment of Perinatal Mental Health and SUDs
How can psychiatric clinicians improve outcomes for this unique patient population?
Improving Medical Education for SUDs With Technology
How can novel technologies help address stigma and improve care for patients with SUDs?
